Marateb, Hamid Reza
von Cube, Maja
Sami, Ramin
Haghjooy Javanmard, Shaghayegh
Mansourian, Marjan
Amra, Babak
Soltaninejad, Forogh
Mortazavi, Mojgan
Adibi, Peyman
Khademi, Nilufar
Sadat Hosseini, Nastaran
Toghyani, Arash
Hassannejad, Razieh
Mañanas, Miquel Angel
Binder, Harald
Wolkewitz, Martin
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (712949)
The Agency for Business Competitiveness of the Government of Catalonia (TECSPR18-1-0017)
Article History
Received: 17 March 2021
Accepted: 17 June 2021
First Online: 14 July 2021
Declarations
:
: The experimental protocol was approved by the ethics committee of the Isfahan University of Medical Sciences (IUMS) and the other national authorities (Longitudinal epidemiologic investigation of patients' characteristics with coronavirus infection referring to Isfahan Khorshid Hospital: IR.MUI.MED.REC.1399.029, Modeling of incidence and outcomes of COVID-19: IR.MUI.RESEARCH.REC.1399.479), conforming to the Declaration of Helsinki. The ethics committee of the IUMS granted permission to use the raw data of the KCC study. Also, the entire subjects gave written informed consent to the experimental procedure. It was given by the first relative family of patients with severe conditions. No minors participated in our study.
: Not applicable.
: The authors declare that they have no competing interests.